FDA Approves Remdesivir to Treat Hospitalized Covid-19 Patients Despite Mixed Trial Results

The Food and Drug Administration has approved remdesivir to treat hospitalized covid-19 patients. The antiviral drug, which is manufactured and sold by the pharmaceutical company Gilead under the brand name Veklury, is the first to be approved for treating the virus in the U.S.

Read more…

via Gizmodo

Check out the Finding Your Identity Podcast